NCT05410028View on ClinicalTrials.gov

New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

March 3, 2022

Primary Completion Date

March 3, 2024

Study Completion Date

March 3, 2026

Conditions

Ovarian Cancer

Interventions

OTHER

No intervention in clinical treatment

No intervention in clinical treatment

Trial Locations (1)

Unknown

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER